The outcome of surgical treatment for elderly patients with gastric carcinoma

BACKGROUND: The aim of this study was to clarify the operative mortality and long‐term survival of gastrectomy for elderly patients with gastric cancer. METHODS: A total of 461 patients who underwent gastrectomy for gastric cancer in our hospital were classified as elderly group (≥80 years‐old, 95 patients) and control group (60–69 years‐old, 366 patients). RESULTS: The frequency of comorbidities was significantly (P < 0.05) higher in elderly group (74.7%) than that in the control group (49.5%). No significant difference of the postoperative complication rate was found between the elderly group (23.2%) and the control group (23.2%). Adjuvant chemotherapy was 9.5% in the elderly group, which was significantly less than 29.0% of the control group (P < 0.05). Stage II and III elderly patients had worse disease specific survival (DSS) than controls did. In the elderly, overall survival (OS) was significantly worse than DSS in stage I patients (P < 0.05). CONCLUSIONS: The operative complication rate of elderly patients was comparable to the control group. Comorbidity and occurrence of secondary malignant disease should be followed for elderly patients at stage I. For stage II and III disease patients, a novel drug which is acceptable for the elderly is needed as a postoperative therapy. J. Surg. Oncol. 2015 111:848–854. © 2015 The Authors. Journal of Surgical Oncology Published by Wiley Periodicals, Inc.